Back to Search
ALAN LIST, MD
MD
Hematology (Internal Medicine) Physician
NPI: 1710908314Individual
Specialties, Licenses & Credentials
Hematology (Internal Medicine) PhysicianPrimary
Internal Medicine — Hematology
Code: 207RH0000X
ME93632(FL)
Research & Publications (20)
Treatment strategies to optimize clinical benefit in the patient with myelodysplastic syndromes.
PMID 18813207·Cancer Control·2008
8-other
Evolving applications of lenalidomide in the management of anemia in myelodysplastic syndromes.
PMID 17242662·Cancer Control·2006
6-review
Lenalidomide: targeted anemia therapy for myelodysplastic syndromes.
PMID 17242661·Cancer Control·2006
6-review
Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion.
PMID 17021321·N Engl J Med·2006
3-trial
Emerging data on IMiDs in the treatment of myelodysplastic syndromes (MDS).
PMID 16085015·Semin Oncol·2005
6-review
Vascular endothelial growth factor receptor-1 and receptor-2 initiate a phosphatidylinositide 3-kinase-dependent clonogenic response in acute myeloid leukemia cells.
PMID 15183893·Exp Hematol·2004
8-other
5-Azacitidine for myelodysplasia before allogeneic hematopoietic cell transplantation.
PMID 19543327·Bone Marrow Transplant·2010
8-other
Outcome of patients with myelodysplastic syndromes in the Veterans Administration population.
PMID 19368972·Leuk Res·2010
8-other
A critical role for phosphatase haplodeficiency in the selective suppression of deletion 5q MDS by lenalidomide.
PMID 19470455·Proc Natl Acad Sci U S A·2009
8-other
Prism adaptation reverses the local processing bias in patients with right temporo-parietal junction lesions.
PMID 19416951·Brain·2009
8-other
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.
PMID 19230772·Lancet Oncol·2009
3-trial
Phase 1 multicenter dose-escalation study of ezatiostat hydrochloride (TLK199 tablets), a novel glutathione analog prodrug, in patients with myelodysplastic syndrome.
PMID 19398716·Blood·2009
3-trial
Advancements in the molecular pathogenesis of myelodysplastic syndrome.
PMID 19468267·Curr Opin Hematol·2009
6-review
Altered naive and memory CD4+ T-cell homeostasis and immunosenescence characterize younger patients with myelodysplastic syndrome.
PMID 19282834·Leukemia·2009
8-other
Durable long-term responses in patients with myelodysplastic syndromes treated with lenalidomide.
PMID 19525184·Clin Lymphoma Myeloma·2009
5-case
A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemia.
PMID 19108889·Leuk Res·2009
3-trial
Identification of a novel inhibitor of JAK2 tyrosine kinase by structure-based virtual screening.
PMID 19447617·Bioorg Med Chem Lett·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 12902 USF MAGNOLIA DR, MDC 44
TAMPA, FL 33612 - Phone
- (813) 745-3980
Quick Facts
- NPI
- 1710908314
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile